Chemical activators of Olr164 include a range of compounds that engage various signaling pathways resulting in the phosphorylation and activation of the protein. Forskolin serves as a direct activator of adenylate cyclase, which catalyzes the conversion of ATP to cAMP, subsequently activating protein kinase A (PKA). PKA then goes on to phosphorylate Olr164, leading to its activation. Similarly, Dibutyryl-cAMP, a synthetic and stable analog of cAMP, bypasses upstream activators and directly activates PKA, which in turn phosphorylates and activates Olr164. Ionomycin and A23187 both function as calcium ionophores, which increase intracellular calcium concentrations. This rise in calcium can activate calcium-dependent kinases, which are capable of phosphorylating Olr164, thereby activating it. Thapsigargin contributes to the activation of Olr164 by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), causing a rise in cytosolic calcium levels which, much like ionomycin and A23187, leads to the activation of calcium-dependent kinases that can target and activate Olr164.
Further activation pathways involve the use of Phorbol 12-myristate 13-acetate (PMA) and DiC8, both of which activate protein kinase C (PKC). PKC directly phosphorylates Olr164, resulting in its activation. Additionally, Okadaic Acid and Calyculin A inhibit protein phosphatases PP1 and PP2A, which typically dephosphorylate proteins. By inhibiting these phosphatases, these compounds maintain Olr164 in a phosphorylated, active state. Anisomycin activates the MAPK/ERK pathway, which can lead to the activation of a cascade of kinases that phosphorylate and activate Olr164. Bisindolylmaleimide I and H-89 are inhibitors of PKC and PKA respectively, but their action can lead to the compensatory activation of alternative kinases which can also phosphorylate and result in activation of Olr164. Each of these chemicals activates distinct pathways that converge on the phosphorylation and subsequent activation of Olr164, showcasing the intricate network of intracellular signaling that can regulate protein function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, raising intracellular calcium levels which can activate calcium-dependent kinases that phosphorylate and activate Olr164. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which phosphorylates and activates Olr164. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases PP1 and PP2A, maintaining proteins like Olr164 in a phosphorylated and activated state. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin stimulates the MAPK/ERK pathway, leading to the activation of kinases that can phosphorylate and activate Olr164. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits SERCA, which leads to an increase in intracellular calcium levels, activating kinases that phosphorylate and activate Olr164. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a stable cAMP analog, activates PKA, which then phosphorylates and activates Olr164. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $47.00 $254.00 | 2 | |
DiC8, as a synthetic analog of diacylglycerol, activates PKC which phosphorylates and activates Olr164. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, like Okadaic Acid, inhibits the phosphatases PP1 and PP2A, leading to the sustained phosphorylation and activation of Olr164. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I inhibits PKC but can lead to the compensatory activation of other kinases capable of phosphorylating and activating Olr164. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 functions as a calcium ionophore like ionomycin, increasing intracellular calcium levels and activating kinases that phosphorylate and lead to the activation of Olr164. | ||||||